MD678F1 - Di-((mju)-O)-di£N-(2-oxo-1-naftal)-N'-(alfa)-oxobenzalhidrazincupru| dihidrat, care manifesta proprietati antimicrobiene selective - Google Patents

Di-((mju)-O)-di£N-(2-oxo-1-naftal)-N'-(alfa)-oxobenzalhidrazincupru| dihidrat, care manifesta proprietati antimicrobiene selective

Info

Publication number
MD678F1
MD678F1 MD960167A MD960167A MD678F1 MD 678 F1 MD678 F1 MD 678F1 MD 960167 A MD960167 A MD 960167A MD 960167 A MD960167 A MD 960167A MD 678 F1 MD678 F1 MD 678F1
Authority
MD
Moldova
Prior art keywords
selective
oxobenzalhydrazinecopper
mju
naphthal
alfa
Prior art date
Application number
MD960167A
Other languages
English (en)
Other versions
MD678G2 (ro
Inventor
Nina Samusi
Viorel Prisacari
Victor Tapcov
Svetlana Buraciov
Original Assignee
Univ De Stat Din Moldova
Univ Nicolae Testemitanu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ De Stat Din Moldova, Univ Nicolae Testemitanu filed Critical Univ De Stat Din Moldova
Priority to MD96-0167A priority Critical patent/MD678G2/ro
Publication of MD678F1 publication Critical patent/MD678F1/ro
Publication of MD678G2 publication Critical patent/MD678G2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MD96-0167A 1996-07-17 1996-07-17 DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective MD678G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD96-0167A MD678G2 (ro) 1996-07-17 1996-07-17 DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD96-0167A MD678G2 (ro) 1996-07-17 1996-07-17 DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective

Publications (2)

Publication Number Publication Date
MD678F1 true MD678F1 (ro) 1997-02-28
MD678G2 MD678G2 (ro) 1997-09-30

Family

ID=19738875

Family Applications (1)

Application Number Title Priority Date Filing Date
MD96-0167A MD678G2 (ro) 1996-07-17 1996-07-17 DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective

Country Status (1)

Country Link
MD (1) MD678G2 (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4174C1 (ro) * 2011-10-25 2013-01-31 Институт Химии Академии Наук Молдовы Derivaţi tiosemicarbazonici ai acidului 4-formil-3-hidroxi-2-naftoic cu proprietăţi antibacteriene

Also Published As

Publication number Publication date
MD678G2 (ro) 1997-09-30

Similar Documents

Publication Publication Date Title
DK1005353T3 (da) Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
AUPO425696A0 (en) A device for preventing or reducing the passage of air through the mouth
EP0675708A1 (en) PHARMACEUTICAL AND DERMOCOSMETIC AGENTS CONTAINING HORSE DECOLOSTRUM.
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
FI964681L (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
MD970143A (ro) Compoziţie farmaceutică
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
ATE406445T1 (de) Genetische sequenzen, welche für enzyme des flavonoid-stoffwechselweges kodieren und deren anwendungen
DE69711006D1 (de) Titanoxid Teilchen, Träger für magnetisches Aufzeichnungsmedium und magnetisches Aufzeignungsmedium diese verwended
DE69225454D1 (de) Bacillus Bakterium und dessen Verwendung
SI1010688T1 (en) Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
DE3683802D1 (de) Alkalische proteasen, diese produzierende mikroorganismen und reinigungsmittel.
ATE107660T1 (de) Therapeutisches mittel.
SG42846A1 (en) Use of enzymes especially bromelain in the treatment of diarrhoea
DK312688D0 (da) Glykkopeptid-antibiotika
MD678G2 (ro) DI-(mu-O)-di[N-(2-oxo-1-naftal)-N'-alfa-oxobenzalhidrazincupru] dihidrat care manifestă proprietăţi antimicrobiene selective
GB9424661D0 (en) Enzymes, microorganisms and their use
Hamann Enhancement of tyrosinase stability by immobilization on nylon 66
IT1213444B (it) Fermenti lattici in associazione simbiotica e loro impiego nella preparazione di prodotti lattiero-caseari ed alimentari in genere.
IL113544A0 (en) Active peptide and its preparation
EP0788301A4 (en) PROCESS FOR REDUCING THE WEAR OF A GRASS
Kipenskaya et al. Effect of Bacillus intermedius ribonucleases with different catalytic activities on the growth of Escherichia coli and Bacillus subtilis
Oh Examination of Undergraduate Medical Education and Management of Medical License
Hampson Consumer culture and social relations: white middle class nostalgia.
MD1435F1 (ro) Capsicozid oxidat cu proprietati antitumorale

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20160717